- Research Letter
- Open Access
Feasibility study of a portable transparent vinyl chloride shield for use in an ambulance during the COVID-19 pandemic
Critical Care volume 24, Article number: 651 (2020)
To the Editor,
An emergency medical technician (EMT) is frequently the first healthcare provider that COVID-19-positive patient encounters, and faces significant risk during procedures with the potential for aerosolization including advanced airway management and cardiopulmonary resuscitation. Polycarbonate devices for shielding droplet splash and aerosols have been adopted by some hospitals . However, placing heavy sizable barriers in an ambulance increases the risk of injury to both the patient and EMT during airway management and may pose kinesthetic challenges and increase time to intubation [2, 3]. Reducing these risks was our highest priority in designing a portable shield for ambulatory care.
The portable shield was fabricated with transparent vinyl chloride in cooperation with HibiiX Co, Ltd (Mizuho, Japan), a company that produces swim floats. The device has a relatively sturdy frame and automatically inflates by lifting the frame upwards. The inflated shield is 50 × 50 × 40 cm and weighs 850 g; the deflated shield is 25 × 20 × 5 cm. There are four ports for the EMTs’ hands, one suction port, six injection/oxygen ports, and a flap on one side (Fig. 1). The device is reusable after disinfection with hypochlorite and ethanol. Recently, the United States Food and Drug Administration recommended that healthcare providers should not use passive protective barrier enclosures without negative pressure, as they may not decrease exposure to airborne particles, and in some circumstances, may increase exposure . Therefore, continuous suction can be applied to maintain negative pressure inside of the shield while in use. Laser-flow visualization demonstrated that with suction to generate negative pressure, the shield reduced aerosol dispersion and exposure to airborne particles (Fig. 2) .
Ten different right-handed EMTs tested the device during a routine training course after providing written consent to participate. Ethics Committee approval was obtained (K2010-008). The participants had worked for a median 10.2 years (range 7–14 years) as tracheal intubation-certified EMTs. During the training session, the EMTs received 30 min of oral instruction on tracheal intubation with video laryngoscopy, insertion of a laryngeal tube (LT), and manual ventilation using a bag-valve mask (BVM). Each EMT then performed ten intubation trials on an adult-sized manikin: five without the shield and five with the shield. Participants were timed and ranked the feasibility of the using the shield on a scale of 1–10. A score of 5 indicated an equal experience to performing the procedure without a shield; 1 was the lowest possible score.
The intubation success rate was 100% for all trials. The average intubation time under the shield was 15.38 ± 11.9 s as compared with 12.6 ± 9.0 s without the shield (p = 0.24; T test analysis). When the feasibility of using the shield was assessed by EMTs, the feasibility scores were 3.6 ± 0.7 for intubation with video laryngoscopy, 3.1 ± 0.7 for insertion of a LT, and 4.2 ± 0.8 for ventilation using a BVM. Finally, we confirmed in patients that the shield did not interfere with BVM ventilation in the ambulance (n = 10) or endotracheal intubation in the emergency department (n = 2).
These data indicate that this lightweight, easy-to-store, vinyl chloride shield is a feasible tool to securely cover the face of a patient during transport and reduces viral exposure, although some aerosol leak may still occur. The shield allowed adequate visualization without loss of function and may reduce the high risk of viral contamination imparted by aerosol-generating procedures during emergency medical transport. The shield design is supported by a recent proof-of-concept study demonstrating that plastic drapes significantly limit aerosolization and droplet spray . Intubation devices should be prepared inside the shield before the suction tube is placed through the side port. Minimizing viral transmission during transport is essential as the world navigates the COVID-19 pandemic.
Availability of data and materials
The data are available from the corresponding author, HN, upon reasonable request.
Coronavirus disease 2019
Emergency medical technician
Leyva-Moraga FA, Leyva-Moraga E, Leyva-Moraga F, Juanz-González A, Ibarra-Celaya JM, Ocejo-Gallegos JA, et al. Aerosol box, an operating room security measure in COVID-19 pandemic. World J Surg. 2020. https://doi.org/10.1007/s00268-020-05724-7.
Canelli R, Connor CW, Gonzalez M, Nozari A, Ortega R. Barrier enclosure during endotracheal intubation. N Engl J Med. 2020. https://doi.org/10.1056/NEJMc2007589.
Rosenblatt WH, Sherman JD. More on barrier enclosure during endotracheal intubation. N Engl J Med. 2020;382(21):e69. https://doi.org/10.1056/NEJMc2012960.
Simpson JP, Wong DN, Verco L, Carter R, Dzidowski M, Chan PY. Measurement of airborne particle exposure during simulated tracheal intubation using various proposed aerosol containment devices during the COVID-19 pandemic. Anaesthesia. 2020. https://doi.org/10.1111/anae.15188.
Freitag S, Clarke AD, Howell SG, Kapustin VN, Campos T, Brekhovskikh VL, et al. Combining airborne gas and aerosol measurements with HYSPLIT: a visualization tool for simultaneous evaluation of air mass history and back trajectory consistency. Atmos Meas Tech. 2014;7:107–28. https://doi.org/10.5194/amt-7-107-2014.
Matava CT, Yu J, Denning S. Clear plastic drapes may be effective at limiting aerosolization and droplet spray during extubation: implications for COVID-19. Can J Anaesth. 2020. https://doi.org/10.1007/s12630-020-01649-w.
We thank Shannon Wyszomierski for editing the manuscript. We thank Dr Kuniaki Gotoh, Department of Applied Chemistry, Okayama University, for technical support to visualize aerosol.
Ethics approval and consent to participate
This study was approved by the Okayama University Ethics Committee (K2010-008).
Written informed consent was obtained for all participants.
Consent for publication
Written informed consent was obtained for all participants.
The authors declare that they have no competing interests. The portable shield for the study was kindly provided by HibiiX Co, Ltd (Mizuho, Japan), without any financial support.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Tsukahara, K., Naito, H., Nojima, T. et al. Feasibility study of a portable transparent vinyl chloride shield for use in an ambulance during the COVID-19 pandemic. Crit Care 24, 651 (2020). https://doi.org/10.1186/s13054-020-03381-9